|
Powered by Cell Signaling Technology |
Site Information |
---|
ERHYDTAkFNCRVAQ SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 27205464 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on PTEN: |
Disease / Diagnostics Relevance | |
---|---|
Relevant diseases: |
References | |
---|---|
Hu Q, et al. (2019) LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. Cell Res 29, 286-304
30631154 Curated Info |
|
Li Y, et al. (2019) PTEN-induced partial epithelial-mesenchymal transition drives diabetic kidney disease. J Clin Invest 129, 1129-1151
30741721 Curated Info |
|
Akimov V, et al. (2018) UbiSite approach for comprehensive mapping of lysine and N-terminal ubiquitination sites. Nat Struct Mol Biol 25, 631-640
29967540 Curated Info |
|
Gupta A, Leslie NR (2016) Controlling PTEN (Phosphatase and Tensin Homolog) Stability: A DOMINANT ROLE FOR LYSINE 66. J Biol Chem 291, 18465-73
27405757 Curated Info |
|
Udeshi ND, et al. (2013) Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments. Mol Cell Proteomics 12, 825-31
23266961 Curated Info |